Our results demonstrated that gp96 was overexpressed in grade IV gliomas (Figure 1(b)), and high gp96 expression was associated with unfavorable outcomes, independent of the malignancy grade (Figures 2(d)–2(i)). Here, HSP90B1 is linked to glioma.